In the BioHarmony Drug Report Database
Efinaconazole
Jublia (efinaconazole) is a small molecule pharmaceutical. Efinaconazole was first approved as Jublia on 2014-06-06. It is used to treat mycoses and onychomycosis in the USA. Jublia’s patents are valid until 2035-04-25 (FDA).
Trade Name
|
Jublia |
|---|---|
Common Name
|
efinaconazole |
ChEMBL ID
|
CHEMBL2103877 |
Indication
|
mycoses, onychomycosis |
Drug Class
|
Systemic antifungals (miconazole type); Fc fusion protein |
Image (chem structure or protein)